Pharmaceuticals · Recorded milestone
GLP-1 weight-loss pills
Recorded year2025
The FDA approves the Wegovy pill, the first daily GLP-1 pill for obesity, in December 2025; Lilly's orforglipron follows in 2026.
Explore this milestone on the interactive mapBuilt on
Led to
Sources & evidence
Dataset updated 2026-10-18. This individual record has not been separately re-reviewed.